Printer Friendly
The Free Library
4,546,731 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Arrowhead Closes $19.6 Million Investment by York Capital Management and Knott Partners.


PASADENA, Calif. -- Arrowhead arrowhead, any plant of the genus Sagittaria, widely distributed marsh or aquatic herbs of the primitive family Alismataceae (water-plantain family). The name derives from the arrowhead-shaped leaves of many species. Native North Americans prepared a potatolike food by roasting or broiling the tubers, particularly of S. latifolia; another species has long been cultivated in China for its starchy root. Research Corporation (NASDAQ:ARWR), a diversified nanotechnology company, today announced that it has received $19.6 million and closed its previously announced private placement. In the offering, institutional investors received 5,590,000 shares of restricted common stock and 1,397,500 warrants to purchase common stock.

About Arrowhead Research Corporation

Arrowhead Research Corporation (www.arrowheadresearch.com) is a diversified nanotechnology company structured to commercialize products expected to have revolutionary impacts on a variety of industries, including materials, electronics, life sciences, and energy.

There are three strategic components to Arrowhead's business model:

--Outsourced R&D Program: Arrowhead identifies patented or patent-pending technologies at universities or government labs and funds additional development of those technologies in exchange for exclusive rights to commercialize the resulting prototypes. Leveraging the resources and infrastructure of these institutions provides Arrowhead with a highly cost-effective development pipeline. Currently, Arrowhead is supporting efforts in nanosensors, stem cell technology, and interconnects for integrated circuits at the California Institute of Technology, Stanford University, and Duke University.

--Commercialization Program: After prototypes have been sufficiently developed in the laboratories, Arrowhead forms or acquires majority-owned subsidiaries to commercialize the technology and provides the subsidiaries with strategic, managerial, and operational support. At present, Arrowhead owns majority interest in subsidiaries commercializing diverse technologies, including anti-cancer drugs, RNAi therapeutics, compound semiconductor materials and carbon nanotube technologies.

--The Patent Toolbox: Arrowhead has acquired or exclusively licensed patents and patent applications covering a broad range of nanotechnology. The Company is actively seeking to add to this intellectual property portfolio.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statement on Form S-3, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 25, 2006
Words:443
Previous Article:Youbet.com to Present at the Brean Murray, Carret & Co. Small Cap Investor Conference on January 31.
Next Article:Nationwide Exchange Services and Cole Taylor Bank Introduce Significant New Services for 1031 Tax-Deferred Exchanges.



Related Articles
LOST BUSINESS COSTS SOUTHLAND.(News)
ON THE THRESHOLD OF CHANGE THINKING OF REPLACING YOUR FRONT DOOR? THE EXPERTS WALK YOU THROUGH IT.(U)
Praedium purchase.(Praedium Group LLC and Essex River Ventures, LLC have bought 186 Lincoln Street and 225 Friend Street in Boston for $19.6...
As 2005 ended, some billion-dollar deals went down in L.A.(News & Analysis)
Arrowhead goes back to school with more money, new partners.(TECHNOLOGY)(York Capital Management)(Brief Article)
Merger activity remains healthy as new year kicks off.(Los Angeles County, California)
M&A Report--January 2006.(Public Notice)
Disney's radio spinoff deal dominated acquisition scene.(BANKING AND FINANCE QUARTERLY M&A REPORT)(Citadel Broadcasting Co.)(Walt Disney Co.)
Univision sale pushes total value of June deals over $20 billion.(NEWS & ANALYSIS)
GVA hospitality team closes $242m in hotel financings.(FINANCE)

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles